Correction of dates for public information on Estimated Primary Completion and Primary Study Completion for a Clinical Phase II study
The clinical Phase II trial with drug resistant metastatic colorectal cancer patients has now been registered at ClinicalTrials.gov .Scandion Oncology hereby informs the market that the information displayed on the public part of Clinicaltrials.gov is not correct: the visible dates for Estimated Primary Completion (May 2021) and Estimated Study Completion (September 2021) are wrongly displayed. The correct dates, which are in full agreement with all previous information from Scandion Oncology, are as